Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimers

Protein in the brain could be a key target in controlling Alzheimer’s

A protein recently discovered in the brain could play a key role in regulating the creation of amyloid beta, the major component of plaques implicated in the development of Alzheimer’s disease, according to researchers at Temple University’s School of Medicine.

A group led by Domenico Pratico, professor of pharmacology and microbiology and immunology at… Protein in the brain could be a key target in controlling Alzheimer’s   



Path Is Found for the Spread of Alzheimer’s

Alzheimer’s disease seems to spread like an infection from brain cell to brain cell, two new studies in mice have found. But instead of viruses or bacteria, what is being spread is a distorted protein known as tau.

The surprising finding answers a longstanding question and has immediate implications for developing treatments, researchers… Path Is Found for the Spread of Alzheimer’s   



Hudson residents banding together to end Alzheimer’s disease

The end of Alzheimer’s disease starts here. The annual Alzheimer’s Association Walk to End Alzheimer’s™ will be held this year Sept. 30 at Quinsigamond Community College in Worcester. To raise awareness and funds for this cause, Hudson residents have formed Team Hudson in the Walk to End Alzheimer’s.

Join in these final days of… Hudson residents banding together to end Alzheimer’s disease   



Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease

There’s new hope in the fight against Huntington’s disease. A group of researchers that includes scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have designed a compound that suppresses symptoms of the devastating disease in mice.

The compound is a synthetic antioxidant that targets mitochondria, an organelle within cells… Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease   



Novel Antibodies for Combating Alzheimer’s and Parkinson’s Disease

Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer’s disease and Parkinson’s disease, as well as Type 2 diabetes, according to a new study.

The onset of these devastating diseases is associated with the inappropriate clumping of proteins into particles that… Novel Antibodies for Combating Alzheimer’s and Parkinson’s Disease   



Tau Transmission Model Opens Doors for New Alzheimer’s, Parkinson’s Therapies

Injecting synthetic tau fibrils into animal models induces Alzheimer’s-like tau tangles and imitates the spread of tau pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania being presented at the American Academy of Neurology’s 65th Annual Meeting in San Diego March 16-23, 2013.

This Alzheimer’s research, along… Tau Transmission Model Opens Doors for New Alzheimer’s, Parkinson’s Therapies   



Cancer drugs block dementia-linked brain inflammation, UCI study finds

A class of drugs developed to treat immune-related conditions and cancer – including one currently in clinical trials for glioblastoma and other tumors – eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.

In their study, assistant professor of neurobiology & behavior Kim Green and colleagues discovered that… Cancer drugs block dementia-linked brain inflammation, UCI study finds   



Cold sore virus increases the risk of dementia

“Our results clearly show that there is a link between infections of herpes simplex virus and the risk of developing Alzheimer’s disease. This also means that we have new opportunities to develop treatment forms to stop the disease,” says Hugo Lövheim, associate professor at the Department of Community Medicine and Rehabilitation, Geriatric Medicine, Umeå… Cold sore virus increases the risk of dementia   



Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons

Enara Herran, a researcher at the UPV/EHU’s Department of Pharmacy and Pharmaceutical Technology, is working to improve the way Alzheimer’s and Parkinson’s treatments are administered. And it is a fact that, as Herran herself stressed, “both diseases are becoming more and more common in our society”.

Both disorders affect the neurones: their structure and… Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons   



Parkinson’s Disease Dementia

pick's disease2 - risk factors for dementia1 - dementia changes1 - olanzapine1 - neuronix1 - iron lady1 - alzheimer's experience1 - difficulties with speech1 - vci1 - alzheimer's brain1 - early alzheimer's disease1 - healthy aging1 - neel nabar1 - alzheimer's signs1 - mini-mental state examination2 - irreversible dementia syndrome1 - movement tremors1 - neurologic disorder1 - neurobiology1 - dementia of the alzheimer type1 - alzheimers society2 - alzheimer's patients7 - senility1 - physical activity2 - postitron emission tomography1 - single-photon emission computed tomography1 - amyloid precursor protein6 - downs syndrome1 - dementia patients care1 - delirious episode1 -